Cargando…
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
Cysteinyl leukotrienes (CysLTs) are potent lipid mediators widely known for their actions in asthma and in allergic rhinitis. Accumulating data highlights their involvement in a broader range of inflammation-associated diseases such as cancer, atopic dermatitis, rheumatoid arthritis, and cardiovascu...
Autores principales: | Gelosa, Paolo, Colazzo, Francesca, Tremoli, Elena, Sironi, Luigi, Castiglioni, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451784/ https://www.ncbi.nlm.nih.gov/pubmed/28607533 http://dx.doi.org/10.1155/2017/3454212 |
Ejemplares similares
-
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
por: Colazzo, Francesca, et al.
Publicado: (2017) -
Expression of dual Nucleotides/Cysteinyl-Leukotrienes Receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction
por: Cosentino, Simona, et al.
Publicado: (2014) -
Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease
por: Nobili, Elena, et al.
Publicado: (2012) -
Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021) -
Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
por: Kanaoka, Yoshihide, et al.
Publicado: (2014)